✦ LIBER ✦

Use of luteinising hormone-releasing hormone agonist (leuprorelin) in advanced post-menopausal breast cancer: clinical and endocrine effects

✍ Scribed by Crighton, IL; Dowsett, M; Lal, A; Man, A; Smith, IE

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II clinical and endocrine study of

✍ Millward, MJ; Cantwell, BMJ; Dowsett, M; Carmichael, J; Harris, AL 📂 Article 📅 1991 🏛 Nature Publishing Group 🌐 English ⚖ 395 KB

Tamoxifen, aminoglutethimide and danazol

✍ Coombes, R C; Powles, T J; Rees, L H; Ratcliffe, W A; Nash, A G; Henk, M; Ford, 📂 Article 📅 1982 🏛 Nature Publishing Group 🌐 English ⚖ 580 KB

A randomized trial exploring the biomark

✍ O. C. Freedman; E. Amir; W. Hanna; H. Kahn; F. O’Malley; G. Dranitsaris; D. E. C 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 257 KB

Hormonal therapy in advanced breast canc

✍ Herbert Volk; Solomon Ciprut; George Escher 📂 Article 📅 1962 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

Hormonal therapy in advanced breast canc

✍ Herbert Volk; Charles J. Foley; Louis J. Sanfilippo; George C. Escher 📂 Article 📅 1964 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB